Search - tctmd.com

Displaying 881 - 900 of 916

Sort: Relevancy | Date

Presentation

All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

Presenter: James K. Min

October 12, 2012

Presentation

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Presenter: Dennis T. Ko

October 10, 2012

Presentation

Trevo vs. Merci Retrievers for Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2)

Presenter: Raul G. Nogueira

August 30, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

Presentation

Retrospective Multicenter Study of Solitaire FR for Revascularization in the Treatment of Acute Ischemic Stroke

Presenter: Antoni D?valos

August 20, 2012

Presentation ACVS 2012

Technical Approach to Lower Limb Revascularization: Available Devices and Clinical Data

Presenter: J. Ezhilan

August 04, 2012

Presentation ACVS 2012

Hybrid Revascularization: What is it and what are the Issues? Cost, Outcomes and Logistics

Presenter: Shantanu Pande

August 03, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation

Ischemia-Guided Revascularization with Myocardial Perfusion Imaging

Presenter: Y.H. Kim

July 10, 2012

Presentation

Exercise Testing in Asymptomatic Patients After Revascularization

Presenter: S. C. Harb

May 23, 2012

Presentation

Appropriateness of Coronary Revascularization for Patients without ACS

Presenter: E.L. Hannan

May 14, 2012

Presentation TCTAP 2012

Risk Scores for Appropriate Left Main Revascularization

Presenter: Corrado Tamburino

April 26, 2012

Presentation TCTAP 2012

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Presenter: Lawrence A. Garcia

April 25, 2012

Presentation Fellows 2012

Revascularization for Stable Ischemic Heart Disease: Guidelines and Clinical Studies

Presenter: Nirat Beohar

April 21, 2012

Presentation

Society for Vascular Surgery (SVS) Vascular Registry Evaluation of Comparative Effectiveness of Carotid Revascularization Stratified by Medicare Age

Presenter: 203143|Jeffrey Jim

April 20, 2012

Presentation

Impact of Completeness of Revascularization on Long-term Cardiovascular Outcomes in Patients with Type 2 Diabetes

Presenter: Leonard Schwartz

April 19, 2012

Presentation

Impact of Anemia on Long-term Clinical Outcome in Patients Undergoing Revascularization with DES

Presenter: T. Pilgrim

April 03, 2012

Presentation ACC 2012

Final Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT)

Presenter: 196412|William Weintraub

March 27, 2012

Presentation CTO 2012

Utility of MSCT in Planning CTO Revascularization

Presenter: Satoru Sumitsuji

February 23, 2012

Presentation CTO 2012

US Perspectives 2: Incorporating Appropriateness Use Criteria into Left Main Revascularization Decisions

Presenter: Manesh Patel

February 22, 2012

Advertisement

All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Trevo vs. Merci Retrievers for Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2)

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Retrospective Multicenter Study of Solitaire FR for Revascularization in the Treatment of Acute Ischemic Stroke

Technical Approach to Lower Limb Revascularization: Available Devices and Clinical Data

Hybrid Revascularization: What is it and what are the Issues? Cost, Outcomes and Logistics

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Ischemia-Guided Revascularization with Myocardial Perfusion Imaging

Exercise Testing in Asymptomatic Patients After Revascularization

Appropriateness of Coronary Revascularization for Patients without ACS

Risk Scores for Appropriate Left Main Revascularization

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Revascularization for Stable Ischemic Heart Disease: Guidelines and Clinical Studies

Society for Vascular Surgery (SVS) Vascular Registry Evaluation of Comparative Effectiveness of Carotid Revascularization Stratified by Medicare Age

Impact of Completeness of Revascularization on Long-term Cardiovascular Outcomes in Patients with Type 2 Diabetes

Impact of Anemia on Long-term Clinical Outcome in Patients Undergoing Revascularization with DES

Final Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT)

Utility of MSCT in Planning CTO Revascularization

US Perspectives 2: Incorporating Appropriateness Use Criteria into Left Main Revascularization Decisions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content